Evidence map›Paper›PMID 35059269›Full record

ArticleDiabetology international2022

Non-autoimmune acute-onset type 1 diabetes mellitus newly developed in an elderly patient presenting elevation of serum pancreatic exocrine enzymes.

Akinori Kanzaki, Morihiro Matsuda, Shinji Yokota, Kenji Takai, Jun Murai, Akihito Otsuka, Hidenori Koyama, Tadashi Nakamura

Erratum issuedAbstract readCase Reports
In one paragraph

Article in Diabetology international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Akinori KanzakiDepartment of Internal Medicine, Medical Corporation Kawasaki Hospital, 3-3-1 Higashiyama-cho, Kobe, Hyogo 652-0042 Japan.ORCID 0000-0003-4447-3064
Morihiro MatsudaDepartment of Internal Medicine, Medical Corporation Kawasaki Hospital, 3-3-1 Higashiyama-cho, Kobe, Hyogo 652-0042 Japan.
Shinji YokotaDepartment of Internal Medicine, Medical Corporation Kawasaki Hospital, 3-3-1 Higashiyama-cho, Kobe, Hyogo 652-0042 Japan.
Kenji TakaiDepartment of Internal Medicine, Medical Corporation Kawasaki Hospital, 3-3-1 Higashiyama-cho, Kobe, Hyogo 652-0042 Japan.
Jun MuraiDepartment of Internal Medicine, Medical Corporation Kawasaki Hospital, 3-3-1 Higashiyama-cho, Kobe, Hyogo 652-0042 Japan.
Akihito OtsukaDepartment of Internal Medicine, Medical Corporation Kawasaki Hospital, 3-3-1 Higashiyama-cho, Kobe, Hyogo 652-0042 Japan.
Hidenori KoyamaDepartment of Diabetes, Endocrinology and Clinical Immunology, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501 Japan.
Tadashi NakamuraDepartment of Internal Medicine, Medical Corporation Kawasaki Hospital, 3-3-1 Higashiyama-cho, Kobe, Hyogo 652-0042 Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An 82 year-old female patient not suffering from diabetes was transported to our hospital with hyperglycemia (HbA1c 8.2%, blood glucose 584 mg/dL) and mildly increased levels of pancreatic exocrine enzymes (amylase 543 IU/L, lipase 59 U/L, elastase-1 479 ng/dL), while there were no findings indicating pancreatitis. Under a diagnosis of new-onset diabetes, she was discharged with oral hypoglycemic agents, as retention of insulin secretion function [blood glucose 117 mg/dL, serum connecting peptide immunoreactivity (CPR) 1.63 ng/mL] with normalization of the enzymes was confirmed following administration. However, at 73 days after the hospitalization, she returned with diabetic ketoacidosis (blood glucose 910 mg/dL, pH in blood gas analysis 7.15, total blood ketone bodies > 7000 µmol/L) with a transient repeated increase of the enzymes (amylase 382 IU/L, lipase 82 U/L, elastase-1 569 ng/dL) and without pancreatitis. Notably, depletion of insulin secretion (6.1 µg/day in urine, 0.36 ng/mL in serum CPR with no response in glucagon-loading test) was revealed, and serum CPR level remained low after discharge. Together with negative findings for islet-related autoantibodies, the patient was diagnosed with acute-onset type 1B diabetes (T1BD). In the present patient with acute-onset T1BD, a mild increase in pancreatic exocrine enzymes was repeatedly observed, which may mimic fulminant type and raise questions for us about the commonly accepted pathophysiology of T1D. These findings may help to clarify issues related to newly developed T1D in elderly individuals.

Indexed as

Case reportNewly developed type 1 diabetes in elderlyNon-autoimmune acute-onset type 1 diabetesPancreatic exocrine enzymes

Identifiers

PMID35059269
PMCPMC8733077

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.